MELPIDAH
Live / Allowed — Publication / registration review complete (as of 19 Oct 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 08 Jul 2026 filing date already counts against anyone who files later.
Record
- Serial number
- 99928840
- Mark type
- Word mark
- Filed
- 08 Jul 2026
- Published for opposition
- 10 Nov 2026
- Attorney of record
- Caroline E. Bryce
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for gene therapy for the treatment of progressive genetic neurological disorders, neurogenetic diseases, neurodegenerative diseases
Owner
- Elpida Therapeutics, Encino, CA, US
Prosecution history
- 07 Oct 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 07 Oct 2026 — ASSIGNED TO EXAMINER
- 08 Jul 2026 — APPLICATION FILING RECEIPT MAILED
- 08 Jul 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 08 Jul 2026 — NEW APPLICATION ENTERED